Home >Current Issue

Volume: 9, Issue: 2, February, 2019
DOI: 10.7324/JAPS.2019.90205

Research Article

Antiproliferative and apoptosis inducing potential of whole plant extracts of Sesuvium portulacastrum against different cancer cell lines

Sathvika Chintalapani, M. S. Swathi, Mangamoori Lakshmi Narasu

  Author Affiliations


Cancer is one of the leading causes of death worldwide. Present treatment options include chemotherapy, radiation therapy, and surgery, all of which have side effects. In order to mitigate the side effects of these treatments, there is a need to look for combinational or alternative treatment, which is based on natural sources. Present study aims to screen the whole plant extracts of Sesuvium portulcastrum for its antiproliferative activity against various cancer cell lines. Different extracts of S. portulacastrum were prepared using ethanol, methanol, acetone, hexane, and diethyl ether as solvent. Their anticancer activity was evaluated against human breast cancer cells (MDA-MB-231), human neuroblastoma cell line (IMR-32), and human colon cancer cells (HCT-116) using the 3-(4,5-dimethylthiazol-2-yl)- 2,5-diphenyltetrazolium bromide (MTT) assay. Propidium iodide staining method was used to observe the apoptosis associated morphological changes under the microscope. Among the five extracts, diethyl ether extract showed the highest activity with IC50 values of 288.69 ± 6.53 μg/ml for MDA-MB-231, 231.01 ± 6.31 μg/ml for IMR-32, and 182.86 ± 4.29 μg/ml for HCT-116 cell lines. Our results suggest that the extracts of S. portulacastrum exhibit good anticancer activity against the different cell lines tested


Sesuvium portulacastrum, MTT assay, apoptosis, anticancer, plant extracts.

Citation: Chintalapani S, Swathi MS, Narasu ML. Antiproliferative and apoptosis inducing potential of whole plant extracts of Sesuvium portulacastrum against different cancer cell lines. J App Pharm Sci, 2019; 9(02):038–043.

Copyright: The Author(s). This is an open access article distributed under the Creative Commons Attribution Non-Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Akindele AJ, Wani ZA, Sharma S, Mahajan G, Satti NK, Adeyemi OO, Mondhe DM, Saxena AK. In Vitro and In Vivo Anticancer Activity of Root Extracts of Sansevieria liberica Gerome and Labroy (Agavaceae). Evid Based Complementary Altern Med, 2015; 2015: 1–11. https://doi.org/10.1155/2015/560404

Anand P, Kunnumakara AB, Sundaram C, Harikumar KB, Tharakan ST, Lai OS, Sung B, Aggarwal BB. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res, 2008; 25(9): 2097−116. https://doi.org/10.1007/s11095-008-9661-9

Chintalapani S, Swathi M.S., Mangamoori LN. Phytochemical screening and in vitro antioxidant activity of whole plant extracts of Sesuvium portulacastrum L. Asian J Pharm Clin Res., 2018; 11(1): 1-6. https://doi.org/10.22159/ajpcr.2018.v11i1.22558

Elmore S. Apoptosis: a review of programmed cell death. Toxicol. Pathol, 2007; 35(4): 495-516. https://doi.org/10.1080/01926230701320337

Haggar FA, Boushey RP. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg, 2009; 22(04): 191-7 https://doi.org/10.1055/s-0029-1242458

Kakde D, Jain D, Shrivastava V, Kakde R, Patil AT. Cancer therapeutics-opportunities, challenges and advances in drug delivery. J App Pharm Sci, 2011; 1(9): 1-10.

Kumar A, Kumari PS, Somasundaram T. Gas chromatography-mass spectrum (GC-MS) analysis of bioactive components of the methanol extract of halophyte, Sesuvium portulacastrum L. Int J Adv Pharm Biol Chem, 2014; 3(3): 766−72.

Lokhande VH, Nikam TD, Ghane SG, Suprasanna P. In vitro culture, plant regeneration and clonal behaviour of S. portulacastrum (L.) L.: a prospective halophyte. Physiol Mol Biol Plants, 2010; 16(2): 187–93. https://doi.org/10.1007/s12298-010-0020-z

Lokhande VH, Gor BK, Desai NS, Nikam TD, Suprasanna P. Sesuvium portulacastrum, a plant for drought, salt stress, sand fixation, food and phytoremediation. A review. Agron Sust Dev. 2013; 33(2):329-48. https://doi.org/10.1007/s13593-012-0113-x

Manikandan M, Kannan K. Pharmacokinetic and pharmacodynamic evaluation of camptothecin encapsulated poly (methacylic acid-co-methyl methacrylate) nanoparticles. J App Pharm Sci, 2017; 7(3): 9-16.

Moller T, Olsson H, Ranstam J. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease. The Lancet, 2002; 360(9328): 187-95. https://doi.org/10.1016/S0140-6736(02)09454-0

Nyamai DW, Arika W, Ogola PE, Njagi EN, Ngugi MP. Medicinally important phytochemicals: An untapped research avenue. Research and Reviews: J Pharmacogn Phytochem. 2016; 4(1) :35-49.

Park JR, Eggert A, Caron H. Neuroblastoma: biology, prognosis, and treatment. Hematol Oncol Clin North Am, 2010; 24: 65-86. https://doi.org/10.1016/j.hoc.2009.11.011

Ramani B, Reeck T, Debez A, Stelzer R, Huchzermeyer B, Schmidt A, et al. Aster tripolium L. and S. portulacastrum L.: two halophytes, two strategies to survive in saline habitats. Plant Physiol Biochem, 2006; 44(5-6): 395–408. https://doi.org/10.1016/j.plaphy.2006.06.007

Rima T, Mangamoori LN. Zerumbone inhibits proliferation and induces apoptosis, cell cycle arrest in human colon cancer cell line, HCT-15. Int J Res Appl Nat Soc Sci, 2017; 5(4): 49−54.

Sharma GN, Dave R, Sanadya J, Sharma P, Sharma KK. Various types and management of breast cancer: An overview. J Adv Pharm Technol Res, 2010; 1(2): 109-26.

Sheela D, Kalavathy U. Anticancer activity of methanol extract of Sesuvium portulacastrum L. whole plant against Ehrlich Ascites carcinoma. Indo Am J Pharm Sci, 2017; 4(11): 4500-6.

Slama I, Ghnaya T, Savouré A, Abdelly C. Combined effects of long-term salinity and soil drying on growth, water relations, nutrient status and proline accumulation of S. portulacastrum. C R Biol, 2008; 331(6): 442–51. https://doi.org/10.1016/j.crvi.2008.03.006

Article Metrics